Gemini normalized the inflammatory response at the cellular level in stage 3 and 4 CKD patients – – Gemini could potentially ...

With obesity and diabetes rising in people as young as their 20s, clinicians face a looming challenge in preventing early ...

ProofPilot, the leading end-to-end clinical experience platform, today announced the acquisition of Lokavant, the clinical trial intelligence company and the premier provider of predictive analytics ...

Discover how Simplify Health Care ETF outperforms with active healthcare stock selection, offering alpha where others see ...

Reaching this stage enables safer care with fewer errors, faster diagnostics, optimised operations, and stronger patient ...

SAN DIEGO, CA / ACCESS Newswire / September 11, 2025 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the “Company” or ...

Hormonal changes associated with menopause may influence the clinical presentation of systemic sclerosis (SSc), according to study findings published in Therapeutic Advances in Musculoskeletal Disease ...

Brown Capital Management, an investment management company, released its “The Brown Capital Management Small Company Fund” ...

Microdosing weight loss drugs, a growing global trend, could offer a new gateway solution for obesity for those priced out of ...

Nuvation Bio stands out as a biotech investment after FDA approval of IBTROZI for ROS1+ NSCLC. Click here to read an analysis ...

Phase 2 TOIVA trial successfully met recruitment target, enrolling 16 subjects at leading vascular anomaly centers; top-line data expected in mid-December 2025 Venous malformations are the most common ...

Novo Nordisk's Rybelsus has become the first oral GLP-1 agonist to pick up a regulatory approval for cardiovascular risk ...